Logo image of SOL

EMEREN GROUP LTD (SOL) Stock Fundamental Analysis

NYSE:SOL - New York Stock Exchange, Inc. - US75971T3014 - ADR - Currency: USD

1.67  +0.12 (+7.74%)

Fundamental Rating

3

SOL gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 51 industry peers in the Construction & Engineering industry. SOL scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. SOL has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year SOL has reported negative net income.
SOL had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: SOL reported negative net income in multiple years.
SOL had a negative operating cash flow in each of the past 5 years.
SOL Yearly Net Income VS EBIT VS OCF VS FCFSOL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

SOL has a Return On Assets of -1.08%. This is in the lower half of the industry: SOL underperforms 70.59% of its industry peers.
Looking at the Return On Equity, with a value of -1.65%, SOL is doing worse than 70.59% of the companies in the same industry.
Industry RankSector Rank
ROA -1.08%
ROE -1.65%
ROIC N/A
ROA(3y)-1.47%
ROA(5y)-0.45%
ROE(3y)-2.16%
ROE(5y)-0.55%
ROIC(3y)N/A
ROIC(5y)N/A
SOL Yearly ROA, ROE, ROICSOL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

Looking at the Gross Margin, with a value of 26.87%, SOL is in the better half of the industry, outperforming 78.43% of the companies in the same industry.
In the last couple of years the Gross Margin of SOL has declined.
SOL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.87%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.71%
GM growth 5Y-1.82%
SOL Yearly Profit, Operating, Gross MarginsSOL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

More info and screens

5

2. Health

2.1 Basic Checks

SOL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SOL has less shares outstanding
The number of shares outstanding for SOL has been increased compared to 5 years ago.
Compared to 1 year ago, SOL has a worse debt to assets ratio.
SOL Yearly Shares OutstandingSOL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
SOL Yearly Total Debt VS Total AssetsSOL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

SOL has an Altman-Z score of -0.52. This is a bad value and indicates that SOL is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.52, SOL is doing worse than 90.20% of the companies in the same industry.
A Debt/Equity ratio of 0.17 indicates that SOL is not too dependend on debt financing.
The Debt to Equity ratio of SOL (0.17) is better than 74.51% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Altman-Z -0.52
ROIC/WACCN/A
WACC9.77%
SOL Yearly LT Debt VS Equity VS FCFSOL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

SOL has a Current Ratio of 4.03. This indicates that SOL is financially healthy and has no problem in meeting its short term obligations.
SOL's Current ratio of 4.03 is amongst the best of the industry. SOL outperforms 100.00% of its industry peers.
A Quick Ratio of 4.03 indicates that SOL has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 4.03, SOL belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.03
Quick Ratio 4.03
SOL Yearly Current Assets VS Current LiabilitesSOL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

4

3. Growth

3.1 Past

SOL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 61.54%, which is quite impressive.
Looking at the last year, SOL shows a very negative growth in Revenue. The Revenue has decreased by -20.25% in the last year.
Measured over the past years, SOL shows a decrease in Revenue. The Revenue has been decreasing by -5.02% on average per year.
EPS 1Y (TTM)61.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%137.5%
Revenue 1Y (TTM)-20.25%
Revenue growth 3Y4.93%
Revenue growth 5Y-5.02%
Sales Q2Q%-44.86%

3.2 Future

Based on estimates for the next years, SOL will show a very strong growth in Earnings Per Share. The EPS will grow by 72.80% on average per year.
Based on estimates for the next years, SOL will show a quite strong growth in Revenue. The Revenue will grow by 11.79% on average per year.
EPS Next Y116.83%
EPS Next 2Y72.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-14.03%
Revenue Next 2Y11.79%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SOL Yearly Revenue VS EstimatesSOL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
SOL Yearly EPS VS EstimatesSOL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.5 -1 -1.5 -2 -2.5

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

SOL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 8.07 indicates a reasonable valuation of SOL.
Based on the Price/Forward Earnings ratio, SOL is valued cheaper than 98.04% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of SOL to the average of the S&P500 Index (21.77), we can say SOL is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 8.07
SOL Price Earnings VS Forward Price EarningsSOL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SOL is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 21.79
SOL Per share dataSOL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SOL's earnings are expected to grow with 72.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y72.8%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SOL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EMEREN GROUP LTD

NYSE:SOL (5/27/2025, 4:10:03 PM)

1.67

+0.12 (+7.74%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)05-14 2025-05-14/bmo
Earnings (Next)08-18 2025-08-18/amc
Inst Owners45.15%
Inst Owner Change-2.6%
Ins Owners1.06%
Ins Owner Change0%
Market Cap85.71M
Analysts80
Price Target4.59 (174.85%)
Short Float %24.27%
Short Ratio3.37
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-92.82%
Min EPS beat(2)-384.65%
Max EPS beat(2)199.01%
EPS beat(4)2
Avg EPS beat(4)-67.17%
Min EPS beat(4)-384.65%
Max EPS beat(4)199.01%
EPS beat(8)3
Avg EPS beat(8)-824.63%
EPS beat(12)4
Avg EPS beat(12)-552.14%
EPS beat(16)6
Avg EPS beat(16)-418.14%
Revenue beat(2)0
Avg Revenue beat(2)-27.74%
Min Revenue beat(2)-40.72%
Max Revenue beat(2)-14.76%
Revenue beat(4)1
Avg Revenue beat(4)-16.47%
Min Revenue beat(4)-51.47%
Max Revenue beat(4)41.07%
Revenue beat(8)2
Avg Revenue beat(8)-16.8%
Revenue beat(12)3
Avg Revenue beat(12)-22.58%
Revenue beat(16)3
Avg Revenue beat(16)-24.91%
PT rev (1m)0%
PT rev (3m)-10%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-112.5%
EPS NY rev (1m)0%
EPS NY rev (3m)-90.28%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-26.58%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-41.78%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 8.07
P/S 1
P/FCF N/A
P/OCF 142.13
P/B 0.28
P/tB 0.28
EV/EBITDA 21.79
EPS(TTM)-0.1
EYN/A
EPS(NY)0.21
Fwd EY12.4%
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)0.01
OCFY0.7%
SpS1.67
BVpS5.92
TBVpS5.92
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.08%
ROE -1.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 26.87%
FCFM N/A
ROA(3y)-1.47%
ROA(5y)-0.45%
ROE(3y)-2.16%
ROE(5y)-0.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.71%
GM growth 5Y-1.82%
F-Score5
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Debt/EBITDA 13.21
Cap/Depr 213.85%
Cap/Sales 18.16%
Interest Coverage N/A
Cash Conversion 15.52%
Profit Quality N/A
Current Ratio 4.03
Quick Ratio 4.03
Altman-Z -0.52
F-Score5
WACC9.77%
ROIC/WACCN/A
Cap/Depr(3y)305.97%
Cap/Depr(5y)240.17%
Cap/Sales(3y)29.54%
Cap/Sales(5y)22.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)61.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%137.5%
EPS Next Y116.83%
EPS Next 2Y72.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-20.25%
Revenue growth 3Y4.93%
Revenue growth 5Y-5.02%
Sales Q2Q%-44.86%
Revenue Next Year-14.03%
Revenue Next 2Y11.79%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y34.63%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year107.38%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y68.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y101.27%
OCF growth 3YN/A
OCF growth 5YN/A